 Connection
Sean O'Leary to Respiratory Syncytial Virus Infections
This is a "connection" page, showing publications Sean O'Leary has written about Respiratory Syncytial Virus Infections.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.803 |
|
|
|
-
Irving SA, Crane B, Weintraub ES, Patel SA, Razzaghi H, Daley MF, Dixon B, Donahue JG, Fuller CC, Fuller S, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Jacobson KB, Kharbanda EO, Maro JC, O'Leary ST, Schmidt T, Sznajder K, Weinfield NS, Williams JTB, Zerbo O, Naleway AL. Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024. Pediatrics. 2025 Jun 01; 155(6).
Score: 0.216
-
Yonts AB, Gaviria-Agudelo C, Kimberlin DW, Paulsen GC, O'Leary ST. June 2024 ACIP Meeting Update: Influenza, COVID-19, RSV, and Other Vaccines. Pediatrics. 2024 Oct 01; 154(4).
Score: 0.206
-
Caserta MT, O'Leary ST, Munoz FM, Ralston SL. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics. 2023 Jul 01; 152(1).
Score: 0.189
-
Hurley LP, Allison MA, Kim L, O'Leary ST, Crane LA, Brtnikova M, Beaty BL, Allen KE, Poser S, Lindley MC, Kempe A. Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults. Vaccine. 2019 01 21; 37(4):565-570.
Score: 0.138
-
Gaviria-Agudelo C, Yonts AB, Kimberlin DW, O'Leary ST, Paulsen GC. October 2024 ACIP Meeting Update: Influenza, COVID-19, RSV, and Other Vaccines. Pediatrics. 2025 Apr 01; 155(4).
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|